Xpan
Xpan Inc. is dedicated to revolutionizing minimally invasive surgery by creating innovative trocar systems that maximize safety, flexibility, and cost-effectiveness. Their flagship product, the Xpan® Universal Trocar System, uses patented expansion technology to accommodate instruments from 3mm to 12mm, aiming to reduce morbidity, increase efficiency, and improve cost outcomes for patients, providers, and hospitals. The company is actively involved in research, clinical validation, and has received FDA clearance and multiple patents for its novel expandable access technology.
Industries
Nr. of Employees
small (1-50)
Products
Universal radially expandable trocar system
A surgical access port designed to enter at a low-profile diameter (~3 mm) and expand via radial dilation to accommodate instruments up to 12 mm, with design features aimed at reducing insertion forces, improving retention, and minimizing fascial trauma.
Universal radially expandable trocar system
A surgical access port designed to enter at a low-profile diameter (~3 mm) and expand via radial dilation to accommodate instruments up to 12 mm, with design features aimed at reducing insertion forces, improving retention, and minimizing fascial trauma.
Services
Collaboration with clinical investigators and institutions to initiate and conduct clinical pilot studies evaluating device performance in minimally invasive surgery.
Collaboration with clinical investigators and institutions to initiate and conduct clinical pilot studies evaluating device performance in minimally invasive surgery.
Expertise Areas
- Minimally invasive surgical device development
- Surgical access port design
- Benchtop biomechanical testing and comparative evaluation
- Preclinical (porcine) study execution for device assessment
Key Technologies
- Radial dilation mechanical expansion
- Expandable surgical access ports
- Benchtop biomechanical testing
- Preclinical porcine model testing
News & Updates
Xpan has obtained FDA 510(k) clearance for its revolutionary radially expandable trocar, enabling clinical and commercial operations and demonstrating its benefits of being less invasive and more flexible.
Xpan has successfully issued two US patents for its expandable trocar technology, protecting its core technology and advanced features for minimally invasive procedures.
Xpan has obtained FDA 510(k) clearance for its revolutionary radially expandable trocar, enabling clinical and commercial operations and demonstrating its benefits of being less invasive and more flexible.
Xpan has successfully issued two US patents for its expandable trocar technology, protecting its core technology and advanced features for minimally invasive procedures.